| RS869312436 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312437 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS869312438 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS869312439 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312440 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312441 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312442 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS869312444 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Thyroid cancer |
| RS869312445 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312446 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312448 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312449 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312450 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312451 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS869312452 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312454 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312455 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312456 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS869312458 |
GLA
|
Health Risk |
Pathogenic |
GLA-related disorder, Fabry disease |
| RS869312463 |
MT-ND1;MT-TL1
|
Health Risk |
Likely pathogenic |
MELAS syndrome, Mitochondrial disease |
| RS869312464 |
PIKFYVE
|
Health Risk |
Pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS869312660 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS869312661 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS869312662 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS869312663 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS869312664 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS869312666 |
MTOR
|
Health Risk |
Pathogenic/Likely pathogenic |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS869312667 |
NBEA
|
Health Risk |
Likely pathogenic |
— |
| RS869312668 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS869312669 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS869312670 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS869312671 |
MTOR
|
Health Risk |
Pathogenic |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS869312672 |
SMC3
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 3, De Lange syndrome |
| RS869312673 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS869312674 |
SYNGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS869312676 |
OPHN1
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS869312677 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS869312678 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS869312681 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation |
| RS869312682 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS869312684 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS869312685 |
ITPR1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 15/16, Spinocerebellar ataxia type 29 |
| RS869312686 |
HCFC1
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS869312687 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Hypertelorism |
| RS869312689 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS869312690 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS869312692 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS869312693 |
DYNC1H1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS869312694 |
MAGEL2
|
Health Risk |
Pathogenic |
Schaaf-Yang syndrome, Schaaf-Yang syndrome |
| RS869312696 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS869312697 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS869312698 |
MEF2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS869312700 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS869312701 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS869312702 |
DNM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS869312703 |
KDM5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS869312704 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Intellectual disability |
| RS869312705 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS869312707 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Dextro-looped transposition of the great arteries |
| RS869312708 |
DYRK1A
|
Health Risk |
Pathogenic/Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS869312709 |
CTR9
|
Health Risk |
Conflicting classifications of pathogenicity |
CTR9-related neurodevelopmental disorder, CTR9-related neurodevelopmental disorder |
| RS869312711 |
KIF1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 9 |
| RS869312712 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS869312713 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS869312714 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS869312718 |
FERMT1
|
Health Risk |
Pathogenic |
Kindler syndrome, Kindler syndrome |
| RS869312721 |
FERMT1
|
Health Risk |
Pathogenic |
Kindler syndrome, Kindler syndrome |
| RS869312723 |
FERMT1
|
Health Risk |
Likely pathogenic |
Kindler syndrome, Kindler syndrome |
| RS869312726 |
FERMT1
|
Health Risk |
Likely pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS869312731 |
FERMT1
|
Health Risk |
Likely pathogenic |
Kindler syndrome, Kindler syndrome |
| RS869312732 |
LIM2
|
Health Risk |
Pathogenic |
Cataract 19 multiple types, Cataract 19 multiple types |
| RS869312733 |
TMEM98
|
Health Risk |
Pathogenic |
Nanophthalmos 4, Nanophthalmos 4 |
| RS869312734 |
TMEM98
|
Health Risk |
Pathogenic |
Nanophthalmos 4, Nanophthalmos 4 |
| RS869312739 |
ACTA1
|
Health Risk |
Pathogenic |
Progressive scapulohumeroperoneal distal myopathy, Actin accumulation myopathy |
| RS869312740 |
MYO18B
|
Health Risk |
Pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Nemaline myopathy |
| RS869312741 |
SMG9
|
Health Risk |
Likely pathogenic |
Heart and brain malformation syndrome, Brainstem dysplasia |
| RS869312742 |
SMG9
|
Health Risk |
Conflicting classifications of pathogenicity |
Heart and brain malformation syndrome, Abnormal facial shape |
| RS869312743 |
FGD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aarskog syndrome, Aarskog syndrome |
| RS869312746 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS869312747 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS869312748 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS869312749 |
S1PR2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 68, Autosomal recessive nonsyndromic hearing loss 68 |
| RS869312750 |
S1PR2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 68, Autosomal recessive nonsyndromic hearing loss 68 |
| RS869312751 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS869312752 |
GLRX5
|
Health Risk |
Pathogenic |
Sideroblastic anemia 3, Sideroblastic anemia 3 |
| RS869312753 |
APC
|
Health Risk |
Pathogenic |
Colorectal cancer, susceptibility to |
| RS869312754 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS869312755 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS869312756 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS869312757 |
BAP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS869312758 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS869312759 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS869312760 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS869312762 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS869312763 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS869312765 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS869312766 |
CTNNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS869312767 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS869312768 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS869312769 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |